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Ten to 15% of couples are infertile, with the most common causes being linked to the production of few or no
oocytes or sperm. Yet, our understanding of human germ cell development is poor, at least in part due to the
inaccessibility of early stages to genetic and developmental studies. Embryonic stem cells (ESCs) provide an
in vitro system to study oocyte development and potentially treat female infertility. However, most studies of
ESC differentiation to oocytes have not documented fundamental properties of endogenous development,
making itdifﬁcult todetermine the physiologic relevanceof differentiated germ cells.Here,we sought toestab-
lish fundamental parameters of oocyte development during ESC differentiation to explore suitability for basic
developmental genetic applications using the mouse as a model prior to translating to the human system. We
demonstrate a timeline of deﬁnitive germ cell differentiation from ESCs in vitro that initially parallels endogen-
ous oocyte development in vivo by single-cell expression proﬁling and analysis of functional milestones
including responsiveness to deﬁned maturation media, shared genetic requirement of Dazl,a n de n t r yi n t o
meiosis. However, ESC-derived oocyte maturation ultimately fails in vitro. To overcome this obstacle, we
transplant ESC-derived oocytes into an ovarian niche to direct their functional maturation and, thereby, pre-
sent rigorous evidence of oocyte physiologic relevance and a potential therapeutic strategy for infertility.
INTRODUCTION
One of the earliest events in human development is the setting
aside, or speciﬁcation, of the cells that are destined to form the
germ cells, the oocytes and sperm, of the adult (1). Germ cell
speciﬁcation occurs in the ﬁrst 3 weeks of development. By
the fourth gestational month in the female, approximately
1000–2000 germ cells migrate from a position outside the
embryo into the genital ridge, proliferate to a population of
ﬁve to seven million and then enter meiosis and differentiate
to oocytes (1). By the ﬁfth gestational month, gradual oocyte
loss begins so that, by birth, there are approximately one
million oocytes in ovarian follicles. In the adult, oocytes
may then encounter one of several fates: they may remain
quiescent, may be recruited for further development and ovu-
lation or may apoptose and die. Over time, without regener-
ation, the oocyte population is depleted in women until less
than a thousand remain and menopause ensues (2–4).
Approximately, 90% of women experience menopause in
their early 50s. Ten percent may experience menopause
prior to 46 years (often termed early menopause), and 1%
may experience menopause at an age ,40 years (frequently
termed premature menopause or premature ovarian failure)
(5,6).
Given these facts, the differentiation of oocytes from
embryonic stem cells (ESCs), for studies of the genetic,
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opment, is merited. Ultimately, the differentiation of func-
tional oocytes from autologous stem cells, such as induced
pluripotent stem cells (iPSCs), potentially provides a means
to understand infertility and treat women with premature
ovarian failure, reproductive aging and/or poor oocyte
quality (7). However, critical aspects of ESC-derived germ
cell development, especially oocyte maturation, have not
been well-documented. Indeed, although several studies have
demonstrated that human ESCs can differentiate into cell
types of somatic and germ lineages including germ cell pre-
cursors, or primordial germ cells (PGCs) (8–13), germ cell
differentiation has been largely limited to the earliest stages.
In contrast to humans, in vitro differentiation of putative
ESC-derived oocytes and follicle-like structures has been
reported in mice (14–18). However, the studies have been dif-
ﬁcult to reproduce, and validation of ESC-derived germ cell
identity, as frequently assessed by expression proﬁle analysis
of ESC-derived populations, has not been straightforward
owing to the heterogeneity of ESC-derived cultures and simi-
larity of genes expressed by ESCs and germ cells/oocytes
(7,8,19). Moreover, physiologic relevance and functional sig-
niﬁcance have been difﬁcult to deﬁne in vitro because very
few germ cells are formed, and correlations of genetic and
functional requirements between endogenous development
and ESC-derived differentiation are lacking (20).
Oocyte enclosure in ovarian follicles shortly after birth in
mice is essential for complete functional oocyte maturation
through interaction with neighboring somatic granulosa cells
in the ovary (21). In the absence of ovarian somatic cells
and follicle formation, as in ectopic oocytes of the adrenal
gland (22) or testes (23), the oocytes rapidly degenerate and
are lost by 3–4 weeks after birth. In addition to the require-
ment of ovarian follicle formation and development for
endogenous oocyte maturation in vivo, functional ex vivo
maturation of oocytes has required fetal-to-newborn-stage
ovary organ culture or transplantation (24–29). Historically,
transplantation into an appropriate stem cell niche has been
necessary to conﬁrm germ and somatic cell identity and func-
tion (30–33).
In this study, we differentiated mouse ESCs to germ cells.
We then characterized and compared the differentiated germ
cells to undifferentiated ESCs at the single-cell level and
further examined functional properties associated with
endogenous oogenesis, such as their responsiveness to
deﬁned maturation media, genetic requirements for germline
formation and maturation and entry into meiosis. Then, to
test the function of oocytes differentiated in vitro and
promote further maturation, we transplanted ESC-derived
germ cells into a synchronized ovarian niche (Fig. 1A).
Finally, we examined the feasibility of using the methods
developed to construct a human fetal ovarian niche for pro-
moting human oocyte development.
RESULTS
Identiﬁcation of germ cells and oocytes in vivo and in vitro
We differentiated mouse ESCs, derived from transgenic mice
carrying a germ cell reporter (DPE Oct4 promoter—GFP
(34)), in vitro and sought to develop an effective strategy to
identify putative ESC-derived germ cell differentiation and
oocyte maturation based on ﬂow cytometry analysis.
However, a major challenge of developing effective methods
to differentiate and isolate germ cells in vitro is the lack of
markers to distinguish germ cells and oocytes from ESCs.
To overcome this challenge, we turned to an examination of
endogenous oocytes in vivo to ﬁnd a suitable method.
Although the Oct4-GFP reporter is expressed in early
embryos and in the germline (35), oocytes from transgenic
embryos expressed the GFP reporter at a low level of intensity
relative to undifferentiated ESCs, PGCs from the genital
ridges of either sex or pro-spermatogonia from fetal testes
by ﬂow cytometry analysis (Supplementary Material,
Fig. S1A). In addition, the cell surface marker, SSEA1 (stage-
speciﬁc embryonic antigen 1), is expressed by undifferentiated
mouse ESCs and PGCs but is not expressed in fetal or adult
gonads after embryonic day 14.5 (e14.5) as reported pre-
viously (36) and conﬁrmed by ﬂow cytometry (Supplementary
Material, Fig. S1B). Therefore, ﬂow cytometry analysis was
used to identify subpopulations of cells based on
Oct4-GFPþ and SSEA12 status, in addition to a low inten-
sity of GFP expression.
After determining that Oct4-GFP intensity, combined with
SSEA1 expression on the cell surface, was diagnostic of
female germ cells in vivo, we differentiated ESCs containing
the Oct4-GFP reporter in suspension as embryoid bodies
(EBs) for up to 21 days in vitro and characterized oocyte
differentiation. EBs were cultured in either standard differen-
tiation media or in media containing a germ cell maturation
factor cocktail (FAC) adapted from a report of endogenous
PGC culture and meiotic progression in the absence of
feeder layer support (37). The FAC cocktail comprised anti-
apoptotic (38), germ cell speciﬁcation (39) and meiotic induc-
tion factors (40), including bone morphogenetic protein 4
(BMP4), retinoic acid, cytochrome p450, 26 (CYP26) inhibi-
tor (R115866), stromal cell-derived factor 1 (SDF1), stem
cell factor (SCF), basic ﬁbroblast growth factor (bFGF),
n-acetyl-cysteine and forskolin. We observed that, whereas
almost all undifferentiated ESCs expressed Oct4-GFP at
high intensity, cells with low-intensity GFP expression were
formed by day 14 of differentiation along with a reduction
in the percentage of cells expressing GFP (Fig. 1B). In
addition, low-intensity GFPþ cells were increased in
numbers and expedited, with the appearance of the low-
intensity population by day 3 of differentiation, following
FAC media treatment (Fig. 1B).
We also note that, concomitant with the appearance of low-
intensity Oct4-GFPþ cells, the percentage of GFPþ/
SSEA12 cells increased by day 14 of differentiation and
was accompanied by a signiﬁcant decrease in the percentage
of double-positive cells as well as an increase in
double-negative cells (Fig. 1C). Together, these observations
indicated that the pattern of putative germ cell differentiation
is similar in timeline to endogenous maturation of PGCs to an
oocyte developmental program on e13.5. Moreover, the ESC-
derived cultures were responsive to FAC media, which
induced a signiﬁcant elevation in the percentage of GFPþ/
SSEA12 and double-negative cells by day 5 of differentiation
along with a corresponding decrease in double-positive cells
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and oocyte maturation, via this methodology, occurred along
an endogenous developmental timeline.
Single-cell analysis of ESC-derived germ cell identity
and maturation
Our knowledge of ESC differentiation to speciﬁc lineages is
derived from analysis of populations of differentiated cells.
For example, in the case of studies of germ cell differentiation
from ESCs, there are no reports of single-cell analysis that
would allow us to distinguish gene expression proﬁles of indi-
vidual ESCs from germ cells and determine the extent of germ
cell maturation. Here, we examined gene expression in single
cells that were differentiated for 5 days and isolated by
ﬂuorescence-activated cell sorting (FACS). Several ﬁndings
emerged from this analysis. First, we observed that transcripts
such as Oct4, Stella, Nanos3 and Vasa, which are expressed
early in germ cell development, were elevated in the double-
positive population, whereas Stra8 (stimulated by retinoic
acid gene 8) and Gdf9, markers of later stages such as
meiotic entry and oocyte maturation, respectively, were
increased in the GFPþ/SSEA12 population (Supplementary
Material, Fig. S2A). Double-negative cells, in contrast,
expressed only minimal levels of germ cell markers. Conver-
sely, somatic cell markers Kdr and Sox1 were elevated in the
double-negative population and minimally expressed in the
GFPþ germ cell populations (Supplementary Material,
Fig. S2A). These results conﬁrmed that the ESC-derived
Oct4-GFPþ populations were enriched for germ cells, and
that double-positive ESC-derived PGCs differentiated toward
either a GFPþ/SSEA12 oocyte fate with low-GFP intensity
along an endogenous timeline of germ cell development or
toward a double-negative somatic cell fate.
Second, when we analyzed gene expression in GFPþ single
cells following 5 days of differentiation in both the absence
and presence of FAC media, we observed that the number
of cells expressing markers diagnostic of germ cells was
greater in the differentiated population than in undifferentiated
ESCs. This included markers of PGCs (early genes: Blimp1,
Stella, Dazl and Vasa) and meiotic germ cells (late genes:
Stra8, Scp1, Scp2, Scp3, Gcnf, Mlh1 and Msy2). Although
Figure 1. ESC-derived germ cell identiﬁcation. (A) In this study, mouse ESCs were differentiated as EBs, and putative DPE Oct4-GFP reporter positive germ
cells were ﬁrst isolated and characterized for germ cell identity and development in vitro. To promote oocyte development, ESC-derived germ cells were sub-
sequently aggregated with ovarian tissue and transplanted. (B) GFP-high and -low intensity populations were identiﬁed above non-transgenic control EBs (solid
peaks) by ﬂow cytometry following Oct4-GFP ESC differentiation in vitro with an increase in the percentage of low-intensity cells by day 14, similar to the
endogenous levels of Oct4-GFP expression observed in fetal ovaries of transgenic mice (D, day). Differentiation in germ cell maturation FAC media
induced a rapid elevation in the percentage of low-intensity cells by day 3 of EB culture. Histogram percentages of high-intensity (gated on GFPþ ESCs)
and low-intensity (gated below GFPþ ESCs and above GFP2 control) populations (X-axis: Oct4-GFP intensity, Y-axis: cell number). (C) The percentage
of the Oct4-GFP and SSEA1 double-positive population decreased signiﬁcantly by day 14 of differentiation along with an increase in the percentage of
GFPþ/SSEA12 and double-negative populations, analogous to endogenous PGC maturation. FAC media induced a signiﬁcant elevation in the percentage
of GFPþ/SSEA12 and reduction in double-positive populations by day 5. Data are represented as mean+SD (n ¼ 3);  P , 0.01 to D12,   P , 0.01 to
D0,    P , 0.05 to D0.
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levels of germ cell marker transcripts (Fig 2A and Supplemen-
tary Material, Fig. S2B), a greater percentage of GFPþ cells
expressed germ cell markers following 5 days of differen-
tiation with or without FAC media for each marker studied
with the exception of Blimp1 in FAC media, which is
known to be downregulated in endogenous PGCs by the
time of oogenesis (41) (Supplementary Material, Fig. S3).
Third, we noted that at the single-cell level, a single
Oct4-GFPþ cell following differentiation was more likely to
express multiple germ cell marker transcripts in the same
cell than an undifferentiated GFPþ ESC. For example, none
of the Oct4-GFPþ ESCs that also expressed Dazl transcript
was found to express more than two additional early or late
germ cell transcripts, with only 14% of ESCs expressing two
early markers (Fig. 2B and C). In contrast, 87% of GFPþ
and Dazlþ cells from day 5 of differentiation without FAC
media expressed two to three additional early germ cell
markers (Fig. 2B), and 70% contained three to ﬁve late
germ cell markers (Fig. 2C). Similar to cells from EBs
without FAC media, 55% of Oct4-GFPþ and Dazlþ cells
from EBs with FAC media expressed two additional early
germ cell markers (Fig. 2B). Furthermore, 81% of GFPþ
and Dazlþ cells from EBs with FAC media contained more
than two late markers with up to seven markers expressed
together in the same cell, which is consistent with functional
FAC media induction of GFPþ germ cell maturation
(Fig. 2C).
Finally, our analysis of single cells indicated that in addition
to expressing a greater number of germ cell markers within the
same cell, single-Oct4-GFPþ cells from day 5 EBs contained
signiﬁcantly elevated levels of most germ cell transcripts ana-
lyzed compared with undifferentiated Oct4-GFPþ ESCs (Sup-
plementary Material, Fig. S4). To summarize, undifferentiated
ESCs occasionally expressed germ cell transcripts, but differ-
entiated ESC-derived germ cells did so more frequently,
Figure 2. Characterization of ESC-derived germ cell identity and maturation. (A) Oct4-GFPþ ESC-derived germ cell identity was conﬁrmed by single-cell
quantitative RT–PCR expression proﬁling of pre-meiotic and meiotic germ cell transcripts before and after 5 days of in vitro differentiation (2/þ) FAC
media. Pre-meiotic germ cell transcripts were enriched in GFPþ cells from 5 day EB cultures, and meiotic transcripts were elevated following differentiation
in FAC media, compared with ESCs. Relative expression: 2
2DCt, relative to Gapdh.( B and C) The percentage values of GFPþ single cells expressing Dazl and
additional early (B) (Blimp1, Stella, Vasa) or late (C) (Stra8, Scp1, Scp2, Scp3, Gcnf, Mlh1, Msy2) germ cell markers by RT–PCR were plotted according to the
number of markers expressed within the same cell. GFPþ cells expressed more early and late marker transcripts in the same cell following differentiation than
undifferentiated ESCs. GFPþ ESCs (blue diamond) did not express more than two additional early or late markers, but GFPþ cells following 5 days of differ-
entiation contained up to three additional early markers (without FAC; green square) (B), or ﬁve (without FAC; green square) and seven (with FAC; purple
triangle) late meiotic transcripts (C) within the same cell.
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also expressed those markers more robustly than undifferen-
tiated ESCs, especially following differentiation in FAC
media.
Genetic requirement of Dazl for ESC-derived germ
cell development
To date, studies of germ cell differentiation from ESCs have
been limited in genetic analysis. To further inspect in vitro
ESC-derived germ cell identity and maturation, ESC lines,
containing the DPE Oct4-GFP reporter, were obtained from
mice carrying a Dazl (Deleted in azoospermia-like) null
mutation and differentiated alongside wild-type (WT) lines.
Dazl null mice are sterile and begin to exhibit a reduction in
germ cell numbers in the pre-committed embryonic genital
ridge by e12.5 in both sexes, with signiﬁcant germ cell loss
by e14.5 in the post-committed fetal ovary or testis
(34,42,43). As expected, Dazl null (knockout—KO) ESC
lines displayed a signiﬁcantly reduced percentage of double-
positive PGCs (15% KO compared with 83% WT) and
GFPþ/SSEA12 germ cells (2% KO compared with 8% WT
without FAC; 2% KO compared with 9% WT with FAC) in
comparison with WT lines by day 12 of differentiation
(Fig. 3). Notably, we did not observe a Dazl null phenotype
after only 7 or 10 days of differentiation without FAC treat-
ment (data not shown).
Hence, the functional genetic requirement of Dazl for germ
cell maturation was shared between endogenous germ cell
development in vivo and ESC-derived germ cell differentiation
in vitro. Moreover, analysis of the Dazl null phenotype also
suggested ESC-derived commitment, or maturation, to a
sex-speciﬁc developmental program by 12 days of in vitro
differentiation without FAC media, thereby paralleling the
manifestation of the Dazl null phenotype by e12.5 in vivo
and corresponding to a timeline of endogenous PGC commit-
ment to an oocyte fate in the absence of signals from the fetal
testis (22,44–46).
ESC-derived oocyte maturation is limited in vitro
Our results above indicated that we had devised a strategy to
isolate and characterize ESC-derived germ cells, that single
cells had distinguishing characteristics of germ cells and that
the genetic requirements for germ cell development in vitro
paralleled those of germ cell development in vivo. However,
a landmark event in germ cell development is the initiation
and progression through meiosis. Thus, we next examined
whether ESC-derived oocytes entered and progressed
through meiosis. As shown, we observed that approximately
1–3% of Oct4-GFPþ cells initiated meiosis, as evidenced
by synaptonemal complex protein (SCP) expression and chro-
mosomal localization (Fig. 4). However, we detected only
partial chromosomal alignment of SCP3, and although other
meiotic proteins such as SCP1 were expressed in the GFPþ
cells, nuclear localization of SCP1 was focal and indicative
of limited meiotic progression (Fig. 4D). We did observe,
however, that CREST centromere staining was occasionally
co-localized telocentrically with the elongated SCP structures
conﬁrming chromosomal alignment (Fig. 4C and E). In
addition, 10% of the GFPþ cells with partial SCP3 alignment
also expressed nuclear g-H2AX, a marker of meiotic DNA
double-strand breaks, in a punctate pattern that co-localized
with regions of the SCP3-coated chromosomes and conﬁrmed
a leptotene–zygotene-like stage of meiotic DNA double-
strand breaks and synapsis (Fig. 4F and G) (47).
In order to optimize meiotic progression, we used an
alternative ESC line that carried a meiotic reporter,
Stra8-GFP, to further examine differentiation in experiments
that paralleled those described above (Supplementary
Material, Fig. S5A–C). Given the role of Stra8 in meiosis, a
greater percentage of the Stra8-GFPþ cells had initiated
meiosis (up to 10–15%), but these cells also exhibited a
block in meiotic progression (Supplementary Material,
Fig. S5D). Furthermore, whereas meiotic cells were detected
by day 15 of differentiation, similar in timeline to endogenous
oogenesis, the maximum percentage of GFPþ germ cells in
meiosis with expression and partial chromosomal localization
of SCP3 was unexpectedly observed by day 5 of ESC differ-
entiation in both cell lines (Fig. 5A and B). Nevertheless,
the analysis of ESC-derived germ cells at these earlier time
points of differentiation, or after treatment with FAC-
supplemented media, did not signiﬁcantly improve the extent
of meiotic progression for either line. In addition, alternative
approaches, based on previous studies of endogenous germ
cell entry into meiosis (44,45,48), also were unable to over-
come the block to meiotic progression, including the
co-culture of the differentiating EBs with female genital
ridge from e11.5 embryos and overexpression of the intrinsic
regulator of meiotic entry and progression, Dazl (data not
shown).
Instead, we observed the most signiﬁcant enhancement of
meiosis in vitro when ESCs were differentiated in co-culture
with dissociated e5.5 embryos. This may reﬂect timing
in vivo, as endogenous PGCs are speciﬁed from the epiblast at
this stage. We observed that e5.5 embryo co-culture induced a
signiﬁcant increase in the percentage of ESC-derived germ
cells initiating meiosis compared with non-co-culture controls
on day 5 of differentiation (14% of Oct4-GFPþ; 30% of
Figure 3. ESC-derived germ cell development requires Dazl. The percentage
of early (Oct4-GFPþ and SSEA1þ; yellow) and late (Oct4-GFPþ and
SSEA12; green) ESC-derived germ cell populations signiﬁcantly decreased,
and GFP2 somatic cells increased, by ﬂow cytometry analysis following
Dazl null (KO, striped bars) ESC differentiation for 12 days (2/þ FAC
media) compared with Dazl WT (solid bars) lines, suggesting in vitro ESC-
derived germ cell commitment, or maturation, along an endogenous develop-
mental timeline with a shared genetic program. Data are represented as
mean+SD (n ¼ 3);  P , 0.05 GFPþ/SSEA12 WT to KO,   P , 0.05
double-positive WT to KO.
4380 Human Molecular Genetics, 2009, Vol. 18, No. 22Stra8-GFPþ) (Fig. 5C). However, as in previous experiments
with alternative strategies, the extent of ESC-derived germ cell
progression through prophase I of meiosis was not improved
by the e5.5 embryo co-culture.
ESC-derived oocyte maturation following ovarian
niche transplantation
Since meiotic progression was incomplete and follicle for-
mation was not observed in vitro, we next sought to test
whether we could achieve oocyte maturation via transplan-
tation (Figs 6 and 7). Ovarian follicle formation occurs just
after birth in mice which have 21 days of gestation, and
re-aggregated newborn ovaries support robust endogenous
ovarian follicle development and oocyte maturation following
transplantation under the kidney capsule (49) (Fig. 7A). Fur-
thermore, our data indicated that in vitro ESC-derived germ
cell differentiation initially followed an endogenous timeline.
Thus, to synchronize ESC-derived oocyte differentiation with
the newborn ovarian niche, we differentiated Oct4-GFP ESCs
for 21 days in vitro without FAC media, isolated GFPþ germ
cells by FACS and co-aggregated the cells with dissociated
WT newborn ovarian tissue. We then transplanted the
co-aggregates under the kidney capsule of recipient mice for
3 weeks. Five out of eight grafts grew in size and contained
ovarian tissue following transplantation. Indeed, we observed
ESC-derived GFPþ cells in two of the grafts. From these
grafts, 23 ESC-derived Oct4-GFPþ oocytes were detected
out of 100 000 cells transplanted for an efﬁciency of 0.023%.
We observed ESC-derived oocytes enclosed in ovarian fol-
licles, with some reaching the primary follicle stage (Fig. 6A–
F) and others at a primordial/primary stage (Figs 6H and 7B)
of development. The primary follicles consisted of an ESC-
derived oocyte that recruited a single layer of endogenous
cuboidal granulosa cells, surrounded by a basement mem-
brane, with robust Oct4-GFP expression above background
staining of endogenous WT oocytes (Fig. 6G and I). In
addition, the oocytes contained a single large germinal
vesicle nucleus and were 10–20 mm in size, equivalent to
the size of endogenous primordial-to-primary follicle-stage
oocytes. We also observed GFPþ oocytes that were not yet
completely enclosed in follicles (Fig. 7C–H) and expressed
the germ cell marker TRA98 and peri-nuclear Balbiani body-
like oocyte marker GM130, but did not express the stem cell/
progenitor marker SSEA1 (Fig. 7F–H) (50).
To further examine GFPþ oocyte origin, we isolated GFPþ
cells by FACS, following transplantation, genotyped them at
50 polymorphic single-nucleotide polymorphism (SNP)
markers across the mouse genome and detected homozygous
parental ESC strain sequence for every marker analyzed but
did not detect WT newborn ovary donor or recipient mouse
strain sequences, thereby conﬁrming an ESC origin of the
Oct4-GFPþ oocytes (Fig. 7I).
Finally, to determine the potential of developing a human
ovarian niche for future studies of human ESC-derived germ
cell transplantation, we obtained human fetal ovaries (after
approval by the appropriate institutional review board) and
transplanted intact or re-aggregated tissues, as described
above, into immuno-deﬁcient mice. Following 2 months of
transplantation, grafts were analyzed for oocyte survival and
development in ovarian follicles (Fig. 8). Intact human fetal
ovaries supported the survival of oocytes in primordial-stage
follicles. Interestingly, after dissociation and re-aggregation,
the human fetal ovaries were still able to support oocyte
Figure 4. ESC-derived oocytes enter meiosis but are limited in meiotic progression in vitro.( A–C) Immunoﬂuorescence staining conﬁrmed Oct4-GFPþ ESC-
derived germ cell meiotic entry and progression by SCP3 nuclear localization and partial chromosomal alignment. (D) SCP1 localized to the nucleus but was
focal instead of elongated, indicating that in vitro ESC-derived meiotic progression was limited. (C and E) CREST centromere staining co-localized with SCP3
and conﬁrmed SCP3 alignment on some, but not all, chromosomes (arrows). (F and G) g-H2AX stain revealed a punctate expression pattern in the nuclei of
GFPþ cells that also co-localized with regions of chromosomal SCP3 and demonstrated the initiation of DNA double-strand breaks and synapsis. Blue is DAPI
except (C) and (E). Magniﬁcation is  630.
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demonstrated the feasibility of physiologic human ovarian
niche transplantation for future studies of human ESC-derived
oocyte maturation.
DISCUSSION
This work documents bona ﬁde oocyte differentiation from
ESCs by describing functional genetic, biochemical and cellu-
lar events that deﬁne endogenous oocyte development in vivo.
The evidence for authentic germ cell differentiation and matu-
ration in this study includes gene expression analysis at the
single-cell level, ability of ESC-derived germ cells to
respond to deﬁned maturation media, a shared requirement
of ESC-derived and endogenous germ cells for the function
of the Dazl gene and ﬁnally, the ability of ESC-derived
oocytes to contribute to folliculogenesis by transplantation
into an ovarian niche. We suggest that the methods and
results outlined above may provide a platform for the develop-
ment of new strategies for regenerative medicine in the arena
of reproductive health.
We ﬁrst present a novel method for the effective isolation of
germ cells and oocytes on the basis of properties of endogen-
ous germ cell development. In contrast to several studies that
used SSEA1 for positive selection and enrichment of early-
stage ESC-derived PGCs (11,13,17,51), we used SSEA1 for
negative selection to allow the isolation of Oct4-GFPþ and
SSEA12 post-PGC-stage germ cells that exhibited properties
of meiosis and maturation. In addition, this method may be
useful for the isolation of later stage human ESC-derived
germ cells because, similar to mouse, SSEA1 expression is
substantially reduced in germ cells of the human fetal ovary
by the end of the ﬁrst trimester upon oocyte initiation of
meiosis (52). Furthermore, SSEA12 selection will help elim-
inate the possibility of teratoma formation following trans-
plantation due to the ectopic reprogramming of human
ESC-derived PGCs (53).
With this method, we were able to isolate and examine
single putative germ cells to conﬁrm germ cell identity and
maturation. To our knowledge, this is the ﬁrst report of ESC-
derived germ cell analysis at the single-cell level and
discrimination of ESC and germ cell gene expression proﬁles.
Single-cell expression proﬁling conﬁrmed that an authentic
ESC-derived germ cell expresses a more coordinated and
extensive set of germ cell-speciﬁc markers compared with
an undifferentiated ESC that may randomly mis-express an
occasional marker during culture.
Furthermore, we expect that ESC-derived germ cells should
possess the ability to respond to endogenous environmental
cues, deﬁned by germ cell maturation FAC media, which
induced the accelerated maturation of germ cells and
oocytes by day 5 of in vitro differentiation. For the ﬁrst
Figure 5. Embryo co-culture improves the initiation of meiosis but conﬁrms an in vitro block to ESC-derived oocyte maturation. (A and B) ESCs containing the
Oct4-GFP or Stra8-GFP reporter were differentiated up to 21 days in standard differentiation media or in media supplemented with FAC. GFPþ germ cells were
isolated by FACS and examined for meiotic entry and progression by SCP3 protein expression and elongated chromosomal localization. The maximum percen-
tage of cells entering meiosis was observed by 5 days of differentiation from both cell lines; however, meiotic progression remained partial, and complete pro-
gression was not detected for any time point, cell line or treatment. Data are represented as mean+SD (n ¼ 3). (C) ESCs were differentiated in suspension for
5 days as EBs without or with dissociated e5.5 embryo co-culture, and GFPþ cells were analyzed for meiosis. The e5.5 embryo co-culture induced a signiﬁcant
increase in the percentage of ESC-derived germ cells that entered meiosis from both cell lines. However, e5.5 embryo co-culture did not improve the extent of
meiotic progression which remained partial. Data are represented as mean+SD (n ¼ 2).  ,  P , 0.05.
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accomplish ESC-derived germ cell maturation. Previous
studies had differentiated mouse ESCs in deﬁned media con-
taining a single factor, such as retinoic acid (15,17,33,51) or
BMPs (9,32,54). However, endogenous germ cells require
multiple factors, such as SDF1 and SCF signaling, from
somatic cells in the genital ridge (55–58) and ovary
(25,59,60). In addition, the CYP26 inhibitor, R115866, was
added to the cocktail in this study to increase the potency of
retinoic acid and prevent its metabolism (44,45). Of note, reti-
noic acid has not yet been used in studies of germ cell differ-
entiation from human ESCs. Retinoic acid may be of
particular importance in promoting human germ cell survival
and meiotic maturation, comparable with mouse (40,61),
since endogenous human germ cells also express STRA8 in
the human fetal ovary by the end of the ﬁrst trimester (62).
Another critical component of this study is the emphasis on
correlating in vivo and in vitro requirements for germ cell
development, such as the function of Dazl. Undifferentiated
ESCs expressing both Oct4-GFP and SSEA1 were not affected
by a homozygous genetic null mutation in the Dazl gene, even
though ESCs express robust levels of Dazl, which was consist-
ent with its germ cell-speciﬁc function. In contrast, the percen-
tage of Dazl null ESC-derived germ cells was signiﬁcantly
reduced by 12 days of differentiation. Thus, ESC-derived
germ cells shared a functional genetic program requirement
and developmental timeline with endogenous germ cells,
further conﬁrming germ cell identity and maturation. Simi-
larly, DAZL, or other germ cell-speciﬁc transcript, knockdown
by RNAi in human ESCs, or differentiation of human iPSCs
from patients with congenital infertility, including Turner syn-
drome, will assist in the validation of human ESC-derived
germ cell differentiation.
Meiosis is a unique functional hallmark of endogenous
germ cell development, and efﬁcient ovarian follicle formation
may require the prior completion of fetal oocyte progression
through prophase I of meiosis (63). Similar to endogenous
fetal oocytes, ESC-derived oocytes also entered meiosis. We
detected SCP3 and g-H2AX expression and localization to
the chromosomes, and SCP1 was expressed in the nucleus,
Figure 6. ESC-derived oocyte maturation in ovarian follicles directed by transplantation into an ovarian niche. (A–D)A nOct4-GFPþ ESC-derived oocyte
enclosed in a primary-stage follicle. (A) Immunoperoxidase stain for GFP expression following transplantation ( 200). (B) Hematoxylin and eosin stain on
adjacent section. (C) Low-magniﬁcation image of (A) showing GFPþ oocyte (solid arrow), GFPþ clusters (arrowhead) and isolated single-GFPþ oocytes
not completely enclosed in follicles (dashed arrow) ( 100). (D) High magniﬁcation of (A) ( 630). (E and F) Additional ESC-derived oocytes in primary fol-
licles with robust GFPþ immunoperoxidase staining above background endogenous GFP2 oocytes (G) derived from WT newborn ovary in the same section
( 630). (H) Oct4-GFPþ ESC-derived oocytes in primordial/primary follicles were also detected by immunoﬂuorescence stain for GFP above background stain-
ing of WT oocytes (I) from newborn ovary located adjacent to (H) ( 630). (A–G) Blue is hematoxylin counter stain. (H and I) Blue is DAPI.
Human Molecular Genetics, 2009, Vol. 18, No. 22 4383indicating that ESC-derived germ cells could enter and pro-
gress through early stages of meiotic prophase I. However,
SCP3 chromosomal alignment remained partial, and SCP1
was not elongated, conﬁrming an in vitro block to ESC-
derived meiotic progression (20). Incomplete meiotic
progression was surprising since endogenous PGCs enter and
progress completely through meiotic prophase I according to
a germ cell-intrinsic timing mechanism (22,37,46,64), and
suggested improper germ cell speciﬁcation in vitro. Encoura-
gingly, e5.5 (germ cell speciﬁcation-stage) embryo co-culture
resulted in a signiﬁcantly increased percentage of ESC-derived
germ cells initiating a meiotic program. However, progression
through prophase I remained partial, revealing that additional
factors, possibly related to germline speciﬁcation, are needed
to direct complete in vitro ESC-derived oocyte meiosis.
Finally, we also noted an in vitro block to ovarian follicle
formation (Fig. 9). Soon after birth in mice, meiotic oocytes
are surrounded by somatic ovarian granulosa cells to form fol-
licles that are essential for functional oocyte maturation. In
fact, endogenous granulosa cells require oocyte-independent
activation of critical signaling pathways to direct sex determi-
nation of the ovary for subsequent oocyte survival and devel-
opment in follicles (65–69). Thus, we co-aggregated and
transplanted ESC-derived meiotic oocytes with newborn
mouse ovarian tissue containing somatic granulosa cells that
are primed to direct follicle formation and oocyte develop-
ment. Transplantation into an appropriate endogenous niche
has traditionally been used as a litmus test of cell type identity
and function. For example, transplantation to germ cell-
depleted testis was used to determine endogenous and ESC-
derived spermatogonial stem cell potential and to achieve
functional spermatogenesis (30,32,33). However, before this
study, transplantation to the ovary had not been used to test
the physiologic relevance of ESC-derived oocytes. Indeed, fol-
lowing transplantation, ESC-derived oocytes integrated into
the ovarian niche, recruited somatic granulosa cells from the
mouse ovary and directed follicle formation and development
to the primary follicle stage (Fig. 9).
Considerable work remains before safe and effective clini-
cal translation can be realized. ESC-derived oocytes in
primary follicles will need to be further matured, fertilized
and shown to support the development of healthy offspring
with respect to karyotype and epigenetic reprogramming. To
promote further maturation, ESC-derived oocytes can be
transplanted for longer periods of time to allow for the
development of antral-stage follicles, or, alternatively, the
primordial-to-primary-stage follicles that were generated in
this study can be isolated and matured in vitro, comparable
with isolated endogenous oocytes in primordial follicles that
later supported the production of offspring (70). Furthermore,
Figure 7. ESC-derived oocyte characterization following transplantation. (A) Hematoxylin and eosin stain of newborn ovarian tissue following re-aggregation
without ESCs and transplantation revealed robust oocyte maturation and folliculogenesis adjacent to kidney tissue ( 100). (B) ESC-derived oocytes (arrows)
enclosedinprimordial/primary-stagefolliclesweredetectedbyimmunoperoxidasestainingforGFPfollowingtransplantation.(CandD)Oct4-GFPþ ESC-derived
oocytes not completely enclosed in follicles. (E) Pre-follicle-stage GFPþ ESC-derived oocytes identiﬁed by immunoﬂuorescence. (F) Oct4-GFPþ and TRA98þ
ESC-derived oocytes not completely enclosed in follicles. (G) GFP and SSEA1 co-stain demonstrated double-positive clusters and isolated Oct4-GFPþ/SSEA12
ESC-derivedoocytes(arrow)( 200).(H)Oct4-GFPþ ESC-derivedoocytesexpressedGM130inBalbianibody-likestructures.(I)TheESCoriginofOct4-GFPþ
oocytes was conﬁrmed by SNP genotyping of FACS isolated cells following transplantation with 100% of GFPþ cell loci homozygous for parental ESC strain
sequence, whereas 0% of GFP2 cell loci were homozygous. (A–D) Blue is hematoxylin counter stain. (E–H) Blue is DAPI. (B–F and H)  630.
4384 Human Molecular Genetics, 2009, Vol. 18, No. 22clinical treatment for female infertility will also require the use
of autologous stem cells, such as iPSCs, for the derivation of
genetically related germ cells (13). Human iPSC-derived germ
cells could then be matured via co-aggregation with human
ovarian tissue and transplantation to a site preferably less inva-
sive than the kidney capsule in order to direct oocyte matu-
ration (71,72). As described in this study, the human fetal
ovarian niche may be suitable for this purpose. However, an
autologous niche would also be advantageous for clinical
translation, including transplantation into the adult ovary of
the patient (73,74) or co-aggregation with iPSC-derived
somatic granulosa cells. Along with many scientiﬁc chal-
lenges, the future derivation of mature gametes from human
stem cells for clinical purposes will be accompanied by
several ethical and policy issues (75).
The clinical relevance of research involving stem cell-
derived oocytes is unquestionable (7). Currently, the options
available for childbearing to women who lack reproductively
competent oocytes are limited to oocyte donation, embryo
donation or adoption. In 2005 in the USA alone, nearly
10 000 fresh and 5000 frozen embryo transfers were per-
formed using donor oocytes (Centers for Disease Control
and Prevention, 2005 Artiﬁcial Reproductive Technology
Report:NationalSummary;http://apps.nccd.cdc.gov/ART2005/
nation05.asp). This number of cycles is most certainly an
underestimate of the true clinical need for functional oocytes,
because not all couples with infertility on the basis of ovarian
failure or diminished ovarian reserve will choose to pursue
oocyte donation. Clearly, more options are needed to allow
women who lack reproductively competent oocytes to have
genetically related offspring, and stem cell-derived oocytes
could someday fulﬁll this need. Research utilizing oocytes
derived from stem cells could also provide valuable insight
into the processes of bothnormaland abnormal oocyte develop-
ment.Itisquiteplausiblethatthisresearchwillnotonlyenhance
our ability to address infertility, but will also help us to under-
stand better some of the causes of abnormal offspring in
spontaneous conceptions occurring among the general
population.
MATERIALS AND METHODS
ESC culture and differentiation
Transgenic DPE Oct4-GFP, Dazl WT and null, ESC (XX)
lines were derived from C57BL/6-FVB/N mice as described
Figure 8. Development of a human ovarian niche via human fetal ovary re-aggregation and transplantation. Intact or re-aggregated 20 week human fetal ovaries
were transplanted under the kidney capsule for 2 months and analyzed for the support of oocyte survival and development in ovarian follicles by hematoxylin and
eosin staining. Oocytes in primordial-stage follicles were present in both samples, indicating that, similar to mouse newborn ovaries, human fetal ovaries sup-
ported the re-organization of follicles following re-aggregation and transplantation and may be utilized for the direction of human ESC-derived oocyte matu-
ration in follicles via transplantation. Arrows show clusters of oocytes in primordial follicles ( 100).
Figure 9. Ovarian niche transplantation surmounts the in vitro ESC-derived oocyte maturation bottleneck. The characterization of germ cell differentiation by
several methods demonstrates that mouse ESCs differentiate in vitro to cells with oocyte-like properties along an endogenous timeline and genetic program,
including the hallmarks of PGC commitment (single star); however, in vitro oocyte maturation is limited (dashed lines represent reduced levels). Transplantation
(double star) into an ovarian niche is required to overcome this in vitro bottleneck and direct physiologic maturation of ESC-derived oocytes in ovarian follicles
(D, days).
Human Molecular Genetics, 2009, Vol. 18, No. 22 4385(34), and the gene trap Stra8-GFP ESC (XY) line was obtained
from the Canadian Mouse Mutant Repository (clone ID
339H10). Undifferentiated ESCs were cultured on irradiated
mouse embryonic ﬁbroblasts in standard ESC media contain-
ing Dulbecco’s modiﬁed Eagle’s medium with high glucose
and 2 mML -glutamine, 1 mM sodium pyruvate, 100 mM non-
essential amino acids, 15% fetal bovine serum (all Invitrogen),
100 mM 2-mercaptoethanol (Sigma) and 1000 U/ml of LIF
(Millipore); plus 165 mg/ml of G418 (Invitrogen) for the
Stra8-GFP gene-trap line only. ESCs were differentiated in
suspension as EBs by culturing in standard EB media with
the same components as ESC media but with 20% fetal
bovine serum (Hyclone) and without LIF on ultra-low attach-
ment plates (Corning). Alternatively, ESCs were differentiated
in FAC media consisting of standard EB media supplemented
with a germ cell factor cocktail: mouse SCF 100 ng/ml, mouse
SDF1 20 ng/ml, mouse bFGF 20 ng/ml, mouse BMP4 50 ng/
ml (all R&D Systems), N-acetylcysteine 1 mg/ml, Forskolin
5 mM, retinoic acid 1 mM (all Sigma) and CYP26 inhibitor
R115866 1 mM (Johnson & Johnson).
Flow cytometry and FACS
ESCs, EBs and fetal gonads were dissociated to single cells
with 0.25% Trypsin (Invitrogen) for 5–10 min at 378C, or
ﬁrst treated with 1 mg/ml each of Collagenase IV and
Dispase (both Invitrogen) for 20 min at 378C prior to trypsini-
zation for adult tissues, and re-suspended in standard media.
Cells were strained through a 40 mm ﬁlter (BD Biosciences)
and then analyzed on a BD-FACSAria cell-sorting system
(BD Biosciences). For ﬂow cytometry analysis of SSEA1
expression, dissociated cells were ﬁrst re-suspended in
phosphate-buffered saline (PBS, Invitrogen) with 1% bovine
serum albumin (BSA, Sigma), incubated with mouse
anti-SSEA1 antibody (1:20, Abcam) for 20 min on ice,
washed, incubated with APC-conjugated anti-mouse IgM sec-
ondary antibody (1:200, Jackson Immunoresearch) for 20 min
and washed again before sorting. GFP and SSEA1 positive
gates were based on non-transgenic control ESC lines and sec-
ondary antibody-only control staining, respectively.
Quantitative gene expression analysis
Gene expression analysis was performed using the BioMark
Dynamic Array (Fluidigm Corporation) microﬂuidics system
for RT–PCR, as described (34). In brief, we pre-ampliﬁed
samples by treating single cells (Fig. 2A and Supplementary
Material, Fig. S2B) or 50 cells (Supplementary Material,
Fig. S2A) per sample per time point following the manufac-
turer’s protocol (Fluidigm Corporation) using TaqMan gene
expression assays (Applied Biosystems) as indicated in the
respective ﬁgures. Then, 2.25 ml of pre-ampliﬁed cDNA was
mixed with 2.5 mlo f2   Universal Master Mix (Applied Bio-
systems) and 0.25 ml of sample loading buffer (Fluidigm Cor-
poration) and loaded into the sample inlets of the 96   96
Dynamic Array (Fluidigm Corporation). For each probe, the
reaction mix contained 2.5 mlo f2   TaqMan Gene Assay
and 2.5 ml of assay loading buffer (Fluidigm Corporation)
for loading into the assay inlets on the Dynamic Array. Each
sample had two technical replicates. Average CT values
were calculated and normalized to Gapdh.
Meiotic cell spread and immunoﬂuorescence
Following ESC, EB or tissue dissociation, cells were
re-suspended in 20 ml of hypo-extraction buffer (pH 8.2)
[30 mM Tris, pH 8.2, 50 mM sucrose, 17 mM citric acid,
5m M EDTA, 0.5 mM DTT and 1% protease inhibitor cocktail
(all Sigma)] for 30 min at room temperature. Then, 60 mlo f
100 mM sucrose was added, and the cell suspension was
spread onto slides pre-coated with 1% paraformaldehyde
(USB Corporation) and 0.15% Triton X-100 (Sigma) in
PBS, pH 9.2, and dried overnight at room temperature.
Slides were blocked in 4% chicken serum (Abcam) and incu-
bated overnight at 48C with primary antibody in TBST [Tris-
buffered saline (TBS), 1% BSA and 0.1% Tween-20 (all
Sigma)] and 1% serum. Primary antibodies included rabbit
anti-SCP3 (1:1000, Abcam), rabbit anti-SCP1 (1:500
Abcam), goat anti-SCP1 (1:50 Santa Cruz), human CREST
(1:100, Antibodies Incorporated) and mouse anti-g-H2AX
(1:500, Millipore). Slides were subsequently incubated with
secondary antibodies for 30 min, and cover slips were
mounted with ProLong Gold Antifade with DAPI (Invitrogen).
Secondary antibodies included chicken anti-rabbit, goat,
mouse (1:1000, Invitrogen) and human (1:250, Aves Labs).
Ovarian tissue aggregation and kidney capsule
transplantation
Newborn ovaries were dissected from WT CD-1 female pups
(Charles River), dissociated to single-cell suspensions by
10 min 0.25% trypsinization and pipetting 10–20 times and
re-suspended in standard EB media. The ovarian cell suspen-
sion from four female pups per graft was then mixed with or
without 100 000 ESC-derived cells post-FACS sort and
0.2 mg/ml of phytohemagglutinin (Sigma). Cell suspensions
were pelleted into grafts at 10 000g for 1 min and incubated
overnight in standard EB media on CM cell culture inserts
(Millipore) at 378C. Grafts were transplanted under the
kidney capsule of bi-laterally ovariectomized CB.17 SCID
recipient mice (Charles River) according to the protocol
approved by the Stanford University Administrative Panel
on Laboratory Animal Care and as described in detail (http://
mammary.nih.gov/tools/mousework/Cunha001/Pages/Written_
Method.html).
Graft and tissue immunohistochemistry
Tissues were ﬁxed overnight in 4% paraformaldehyde (USB
Corporation), embedded in parafﬁn and sectioned. In brief,
sections on slides were de-parafﬁnized, re-hydrated, antigens
unmasked by boiling in Target Retrieval Solution (Dako) for
30 min, permeabilized in 0.1% Triton X-100 (Sigma) for
5 min, blocked with 10% chicken serum in TBST overnight
and incubated with primary antibody in TBST with 1%
serum for 1 h at room temperature. Primary antibodies
included anti-GFP rabbit monoclonal (1:1000, Abcam),
anti-TRA98 rat monoclonal (1:500, B-Bridge), anti-SSEA1
mouse monoclonal (1:100, Abcam or Developmental Studies
4386 Human Molecular Genetics, 2009, Vol. 18, No. 22Hybridoma Bank) and anti-GM130 mouse monocolonal
(1:100, BD Biosciences). After washing in TBST, slides
were incubated with secondary antibody for 30 min at room
temperature. For immunoﬂuorescence, secondary antibodies
included chicken anti-rabbit, rat and mouse (1:1000, Invitro-
gen), and coverslips were mounted with Prolong Gold Anti-
fade with DAPI (Invitrogen). For immunoperoxidase, slides
were treated as above but with additional blocking in 10%
hydrogen peroxide (Sigma) for 20 min at room temperature
before permeabilization. Slides were blocked overnight with
10% goat serum (Abcam) in TBST and incubated with
primary antibody for 1 h, biotinylated goat anti-rabbit second-
ary antibody (1:200, Vector Labs) for 30 min, Vectastain ABC
solution (Vector Labs) for 30 min, Immpact DAB substrate
(Vector Labs) for 1–5 min, counterstained with Mayer’s
hematoxylin and mounted with Prolong Gold Antifade
(Invitrogen).
Genetic analysis post-transplantation
After 3 weeks of transplantation, grafts were harvested, disso-
ciated and Oct4-GFP positive and negative cells isolated by
FACS. Genomic DNA was prepared from these populations,
and from the parental Oct4-GFP ESC line (DNeasy,
Qiagen), and was then analyzed for the sequence of 50
SNPs that were polymorphic between C57BL/6-FVB/N and
CD1-BALB/C mouse strains by the Jackson Laboratory
Genome Scanning Service. The SNP panel contained three
markers on chromosomes 1, 2, 3, 4, 5, 6, 7, 8, 9, 10 and 12,
two markers on chromosomes 11, 13, 14, 15, 16, 17, 18 and
19, and one marker on the X chromosome. SNP sequences
at each locus were compared with the parental ESC line and
to each of the four mouse strains using a modiﬁed Ampliﬂuor
ﬂuorescent PCR-based system.
Statistical analysis
Data are represented as mean+standard deviation (SD). Stat-
istical signiﬁcance was determined with Excel (Microsoft)
using an unpaired Student’s t-test with two-tailed distribution
of two-sample unequal variance. Signiﬁcance of values in
Supplementary Material, Fig. S4 was determined by Prism
(GraphPad Software) two-way ANOVA with Bonferroni
post-test.
SUPPLEMENTARY MATERIAL
Supplementary Material is available at HMG online.
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